A detailed history of Eaton Vance Management transactions in Repligen Corp stock. As of the latest transaction made, Eaton Vance Management holds 102,218 shares of RGEN stock, worth $14.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
102,218
Previous 144,300 29.16%
Holding current value
$14.8 Million
Previous $23.4 Million 18.38%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $6.75 Million - $10.8 Million
-42,082 Reduced 29.16%
102,218 $19.1 Million
Q2 2022

Aug 15, 2022

SELL
$140.68 - $188.02 $73,716 - $98,522
-524 Reduced 0.36%
144,300 $23.4 Million
Q1 2022

May 16, 2022

BUY
$161.19 - $257.96 $1.93 Million - $3.09 Million
11,992 Added 9.03%
144,824 $27.2 Million
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $33,919 - $41,712
137 Added 0.1%
132,832 $34.9 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $96,995 - $161,456
-498 Reduced 0.37%
132,695 $38.1 Million
Q2 2021

Aug 16, 2021

BUY
$165.87 - $220.95 $180,466 - $240,393
1,088 Added 0.82%
133,193 $26.6 Million
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $48,339 - $60,637
268 Added 0.2%
132,105 $25.7 Million
Q4 2020

Feb 12, 2021

BUY
$148.08 - $206.57 $7,848 - $10,948
53 Added 0.04%
131,837 $25.3 Million
Q2 2020

Aug 13, 2020

BUY
$94.33 - $140.48 $3,773 - $5,619
40 Added 0.03%
131,784 $16.3 Million
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $7,205 - $8,977
94 Added 0.07%
131,744 $10.1 Million
Q1 2019

May 14, 2019

SELL
$49.45 - $62.8 $2,818 - $3,579
-57 Reduced 0.04%
131,650 $7.78 Million
Q4 2018

Feb 07, 2019

BUY
$48.26 - $68.88 $2,750 - $3,926
57 Added 0.04%
131,707 $6.95 Million
Q2 2018

Aug 10, 2018

BUY
$35.26 - $47.04 $4.19 Million - $5.59 Million
118,870 Added 930.13%
131,650 $6.19 Million
Q4 2017

Feb 12, 2018

BUY
$32.53 - $38.92 $390 - $467
12 Added 0.09%
12,780 $464,000
Q3 2017

Nov 13, 2017

BUY
$36.98 - $46.06 $472,160 - $588,094
12,768
12,768 $489,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.